Fundz

Athos Therapeutics, Inc.

Los Angeles, United States · Biotechnology, Healthcare, Health Care

Athos Therapeutics Inc. is a late-stage preclinical biotech company developing small molecule therapeutics for immune-mediated diseases and cancer using artificial intelligence-generated innovative chemistry and computational platforms. The co-founders of Athos include one of the founders of Kite Pharma (acquired for $12B), the medicinal chemist behind two multi-billion-dollar FDA-approved drugs (

Key facts

Headquarters
Los Angeles, United States
Employees
Unknown
Industries
Biotechnology, Healthcare, Health Care
Status
Private
Website
athostx.com
LinkedIn
Company page

Recent activity at Athos Therapeutics, Inc.

Athos Therapeutics, Inc. funding history

DateRoundAmount
May 2026Venture$10.3M
Feb 2024Venture$20.4M
Nov 2021Series AUndisclosed
Sep 2021Venture$13.2M

Leadership

  • Dimitrios Iliopoulos, Executive Officer, Director
  • Allan Pantuck, Executive Officer, Director
  • Carl McKinzie, Director
  • Joel Cohen, Director
  • Keith Hoffman, Chief Business Officer

Verified email and direct lines for Athos Therapeutics, Inc.’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Athos Therapeutics, Inc. in the news

Companies similar to Athos Therapeutics, Inc.

About Athos Therapeutics, Inc.: questions and answers

What does Athos Therapeutics, Inc. do?

Athos Therapeutics Inc. is a late-stage preclinical biotech company developing small molecule therapeutics for immune-mediated diseases and cancer using artificial intelligence-generated innovative chemistry and computational platforms. The co-founders of Athos include one of the founders of Kite Pharma (acquired for $12B), the medicinal chemist behind two multi-billion-dollar FDA-approved drugs (

Where is Athos Therapeutics, Inc. headquartered?

Athos Therapeutics, Inc. is headquartered in Los Angeles, United States.

Has Athos Therapeutics, Inc. raised funding?

Yes. Fundz has recorded 4 funding events for Athos Therapeutics, Inc.. The most recent, $10.3M, was in May 2026.

What is the latest news on Athos Therapeutics, Inc.?

On May 15, 2026, Athos Therapeutics

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Athos Therapeutics, Inc. across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.